PureTech Health plc - ADR

The momentum for this stock is not very good. PureTech Health plc - ADR is not a good growth stock. PureTech Health plc - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in PureTech Health plc - ADR.
Log in to see more information.

News

PureTech Health (NASDAQ:PRTC) Now Covered by Leerink Partners
PureTech Health (NASDAQ:PRTC) Now Covered by Leerink Partners

Ticker Report Stock analysts at Leerink Partners started coverage on shares of PureTech Health (NASDAQ:PRTC - Get Free Report) in a research report issued on Monday, MarketBeat.com reports. The brokerage set an...\n more…

PureTech Health (NASDAQ:PRTC) Upgraded to Strong-Buy at Leerink Partnrs
PureTech Health (NASDAQ:PRTC) Upgraded to Strong-Buy at Leerink Partnrs

Ticker Report Leerink Partnrs upgraded shares of PureTech Health (NASDAQ:PRTC - Free Report) to a strong-buy rating in a report released on Monday, Zacks.com reports. Separately, Leerink Partners started coverage...\n more…

PureTech Health (NASDAQ:PRTC) Coverage Initiated by Analysts at Leerink Partners
PureTech Health (NASDAQ:PRTC) Coverage Initiated by Analysts at Leerink Partners

Zolmax Leerink Partners initiated coverage on shares of PureTech Health (NASDAQ:PRTC - Free Report) in a research report sent to investors on Monday, Marketbeat.com reports. The firm issued an outperform...\n more…

PureTech Health assumed with an Outperform at Leerink
PureTech Health assumed with an Outperform at Leerink

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Citigroup Adjusts Stake in PureTech Health
Citigroup Adjusts Stake in PureTech Health

TipRanks Financial Blog PureTech Health (GB:PRTC) has released an update. Citigroup Global Markets Limited has notified PureTech Health PLC of a change in their voting rights, crossing the...\n more…

PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

Business Wire PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that...\n more…